Feds fine St. Louis drug maker $3.5 million

Jul 19, 2013 by Paul Elias

(AP)—A St. Louis-based drug maker is paying $3.5 million to settle a federal lawsuit that it illegally paid doctors to prescribe out-of-date antidepressants and sleep aids to Medicare and Medicaid patients.

The U.S. attorney's office in San Francisco announced the settlement Thursday. Prosecutors say a former employee of drug maker Mallinckrodt LLC initially filed the lawsuit in 2008 under the federal False Claims Act.

The employee alleged the company paid doctors consulting fees and other inducements for prescribing several of its drugs.

According to the lawsuit, the drugs were "third rate" treatments that would not typically have been prescribed without the inducements. The government joined the lawsuit because Medicare and Medicaid paid for some of the prescriptions.

A Mallinckrodt spokesman says the company is glad the matter is resolved.

Explore further: Sony forecasts $2B loss as smartphones lag (Update)

not rated yet
add to favorites email to friend print save as pdf

Related Stories

US sues Novartis in NY again, cites doc kickbacks

Apr 26, 2013

The U.S. government sued Novartis Pharmaceuticals Corp. again on Friday, saying it paid kickbacks for a decade to doctors to steer patients toward its drugs, sometimes disguising fishing trips off the Florida coast and trips ...

NY lawsuit accuses Novartis of health care fraud

Apr 24, 2013

The U.S. government sued Novartis Pharmaceuticals Corp. Tuesday, claiming it gave kickbacks to pharmacies to switch kidney transplant patients from competitors' drugs to its own.

Inspector highlights psych drug use among elderly

Nov 30, 2011

(AP) -- Government inspectors will tell lawmakers Wednesday that the Medicare health plan needs to do more to stop doctors from prescribing powerful psychiatric drugs to nursing home patients with dementia, an unapproved ...

Pfizer disputes suit claiming Zoloft doesn't work

Jan 31, 2013

(AP)—The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill. The federal lawsuit, filed in California, argues that patients who took it should be reimbursed ...

Recommended for you

Germany's Bayer says will float chemicals division

2 hours ago

German chemicals and pharmaceuticals giant Bayer, maker of Aspirin painkiller, said on Thursday it intends to float its chemicals Material Science division to focus on its life sciences activities in human and animal health.

Sony forecasts $2B loss as smartphones lag (Update)

Sep 17, 2014

Sony expects its annual loss to swell to $2 billion and has canceled dividends for the first time in more than half a century after writing down the value of its troubled smartphone business.

Alibaba post-IPO structure gives insiders control

Sep 17, 2014

Control over Alibaba Group will stay in the hands of founder Jack Ma and other company veterans after the Chinese e-commerce giant goes public on the New York Stock Exchange in a record busting share sale.

User comments : 0